End-to-end analytical assay packages, compound characterization, and clinical phase evaluations tailored to international pharmacopeia compliance.
Bridging classical pharmacognosy with modern molecular analytics, high-throughput extraction, and international cGMP manufacturing standards.
In the global biopharmaceutical and high-tier nutraceutical landscapes, botanical chemical sourcing has undergone an essential paradigm shift. International procurers and formulation developers no longer accept rudimentary, unstandardized dry extracts that display wild batch-to-batch variations. The modern market strictly dictates standardized secondary metabolites, characterized chemical fingerprints, and full traceability spanning agrochemical control down to micro-level chromatographic assays.
MedGence (Yineng Pharma), established in Changsha, Hunan, operates at the core of this industrial convergence. With extensive integration of Traditional Chinese Medicine (TCM) phytochemistry and automated continuous extraction equipment, our facility overcomes intrinsic natural variations, guaranteeing repeatable molecular integrity across multi-metric ton batch outputs.
The strategic symbiosis of bio-resource biodiversity, chemical engineering infrastructure, and capital efficiency.
China is home to over 11,000 medicinal plant species. This vast bio-diversity enables factory access to authentic geo-herbal (Daodi) materials directly at source, minimizing intercontinental raw-biomass degradation and ensuring peak bio-potency upon initial maceration.
Chinese production bases utilize massive supercritical CO₂ fluid extractors, automated countercurrent solvent lines, and macro-porous resin adsorptions. Large vessel capacities dramatically lower per-kilogram energy expenditure compared to European and North American facilities.
Equipped with ICP-MS and tandem GC-MS/MS, advanced Chinese facilities routinely strip trace agrochemical residues, polycyclic aromatic hydrocarbons (PAHs), and toxic elemental contaminants to satisfy USP, Ph. Eur., and California Prop 65 safety thresholds.
Emerging technologies replacing traditional solvent boiling to achieve high purity, bio-potency, and clean-label integrity.
Traditional non-specific UV/Vis spectrometry is being substituted by ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF/MS). This provides precise multicomponent structural mapping across complex botanical matrixes.
Targeted hydrolysis using immobilized pectinases and cellulases selectively cleaves sugar moieties from bound saponins and flavonoids. This conversion markedly enhances gut permeability, bioavailability, and physiological absorption kinetics in vivo.
Replacing toxic petroleum solvents with deep eutectic solvents (DES) and subcritical water extraction, paired with multi-stage ceramic nanofiltration membranes, permits thermal-sensitive molecule preservation with zero volatile organic emissions.
Meeting application requirements across dynamic global industrial spaces.
Liquid clarity, zero precipitate formation, and thermal stabilization are critical for ready-to-drink functional beverages. Our cold-water-soluble botanical extracts and micro-encapsulated polyphenol powders eliminate turbidity and off-flavors.
Tableting speed, high bulk density, and low hygroscopicity govern success in modern capsule and tablet packaging. We calibrate fluidized-bed spray-dried granules to provide optimal flowability and uniform direct compression properties.
For skincare serums and barrier emulsions, botanical molecules must exhibit minimal color transfer, negligible photo-toxicity, and high dermal affinity. We isolate non-pigmented terpenoids and purified triterpenes that promote dermal barrier repair.
How our turnkey contract platform handles raw material variance, standard verification, pilot scale-up, and clinical dossiers.
Taxonomic verification of plant tissue, heavy metal assay, multi-residue pesticide screen, and geographic origin benchmarking to eliminate adulterants at the factory door.
Solid-liquid ratio optimization, fractional solvent recovery distillation, and crystallization parameters defined in pilot tanks to secure high extraction yields.
Comprehensive in vitro cell line evaluations, cellular oxidative stress markers, acute LD50 determinations, and GLP-compliant 90-day sub-chronic animal models.
Full scale-up in GMP-certified clean rooms, delivering commercial batches packed under nitrogen flushing, backed by full Certificate of Analysis (CoA) documentation.
Addressing regulatory stringency, supply disruptions, and analytical transparency for overseas buyers.
Procurement directors require seamless cross-referencing against USP, EP, CP, and JP monographs. MedGence produces analytical method validation packages with peak-purity guarantees and complete chromatographic raw files.
Geopolitical tariffs and sea freight bottlenecks necessitate raw inventory reserves. We maintain dual-channel feedstock reserves across multiple agricultural regions to ensure continuous, non-delayed finished extract delivery.
Protecting novel formulation balance, unique solvent mixtures, and processing IP is essential. MedGence operates on an entrusted, ring-fenced contract research paradigm where customer formulas are kept strictly proprietary.
Delivering proven contract analytical science to national hospitals and publicly listed pharma groups.
Beijing Tongrentang
CR Sanjiu Medical
Sunflower Pharma
Livzon Pharma
Dihon Pharma
Golden Throat
Yangtzi River Pharma
Humanwell Group
Apeloa Pharma
Shuguang Hospital
Second Xiangya Hospital
First Hospital Hunan TCM
Technical and logistical insights for buyers, quality directors, and chief scientific officers.
Select your target research service or extract specification to initiate pilot formulation or high-volume procurement.
